Ignite Creation Date:
2025-12-24 @ 3:25 PM
Ignite Modification Date:
2026-01-04 @ 3:41 AM
Study NCT ID:
NCT04830592
Status:
COMPLETED
Last Update Posted:
2025-03-24
First Post:
2021-03-31
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of NG-641 and Pembrolizumab in Squamous Cell Carcinoma of the Head and Neck
Sponsor:
Akamis Bio
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
NG-641-02
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None